Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acute, Advisor, ahead, analyze, analyzed, anatomical, angiography, arm, automated, Bain, Barone, BCVA, Benitec, BioFactoryTMplatform, Biopharma, bleb, caveat, cent, CI, clustered, CNV, cone, conjunctival, Constructive, copy, CVD, cyst, disorder, District, dosage, dose, durable, endpoint, epiretinal, epithelial, ERM, exam, exudative, Fifty, fluid, fluorescein, foregoing, forfeited, formation, fourth, Gasmi, group, guide, hereto, heterogeneity, hindered, Hull, infarction, inference, insusceptible, intraoperative, intraretinal, intravitreal, leakage, library, Linda, lump, macula, median, Mehdi, membrane, merit, moderate, monthly, move, myocardial, Northern, OCT, opsin, optimize, phakic, pigment, point, preceding, Preliminary, premium, preserving, pseudophakic, purported, qualitative, race, randomized, ranibizumab, reallocate, recipient, recurrent, Release, remeasured, reoccurrence, resignation, resigned, resolution, respond, resume, retrospective, Roman, RSU, Rubio, salary, sample, Samuel, sequelae, sight, startup, submacular, suggest, sum, surgical, SVP, technique, text, traction, Treatability, uncommon, understanding, unforfeitable, uniformly, unspecified, unvested, variation, video, vigorously, visit, vitreomacular, Week
Filing tables
Filing exhibits
Related press release
ADVM similar filings
Filing view
External links
Exhibit 10.5
[Avalanche Biotechnologies, Inc. letterhead]
August 11, 2015
Mehdi Gasmi
1035 O’Brien Drive
Suite A
Menlo Park, California 94025
Re: Base Salary Increase
Dear Mehdi:
Pursuant to your Special Bonus Letter, dated July 23, 2015, you were notified of the Special Bonus of $100,000 for your services as interim Chief Scientific Officer.
In addition to the Special Bonus, effective August 15, 2015, the Board of Directors of Avalanche Biotechnologies, Inc. has determined to increase your annual base salary to $330,000 per year.
We greatly appreciate your services to the Company during this transition time.
Sincerely, |
/s/ Mark S. Blumenkranz
Mark S. Blumenkranz, M.D. Chairman of the Board |